## Clinical Diagnosis and Rationale **Key Point:** This patient has seropositive myasthenia gravis (MG) with an associated anterior mediastinal mass (thymoma), making thymectomy the definitive surgical intervention. ### Why Thymectomy is Indicated 1. **Thymoma Association**: The presence of a mediastinal mass on imaging in a patient with seropositive MG strongly suggests thymoma (present in ~10–15% of MG patients). 2. **Surgical Benefit**: Thymectomy is the standard of care for MG with thymoma, with remission rates of 30–50% and significant improvement in 80% of patients [cite:Harrison 21e Ch 378]. 3. **Immediate Symptom Control**: Pyridostigmine should be started concurrently to provide rapid symptomatic relief while awaiting surgery. ### Management Algorithm ```mermaid flowchart TD A[Seropositive MG + Mediastinal Mass]:::outcome --> B{Thymoma confirmed?}:::decision B -->|Yes| C[Start Pyridostigmine for symptom control]:::action C --> D[Arrange Thymectomy]:::action D --> E[Remission/Improvement in 80%]:::outcome B -->|No| F[Consider immunosuppression]:::action ``` **High-Yield:** Thymectomy should be performed as soon as feasible in thymoma-associated MG; delaying surgery worsens long-term prognosis. ### Symptomatic Management - **Pyridostigmine**: Acetylcholinesterase inhibitor; provides rapid symptom relief by increasing acetylcholine at the neuromuscular junction. - **Dosing**: 60 mg TDS is standard; can be titrated up to 120 mg TDS based on response. - **Onset**: Symptomatic improvement within hours to days. **Clinical Pearl:** The ice pack test (improvement of ptosis after 2–3 minutes of ice application) is a bedside confirmatory test for MG and was positive in this patient, supporting the diagnosis. ### Why Other Agents Are Not First-Line Here - **IVIG/Plasmapheresis**: Reserved for myasthenic crisis or acute exacerbations; not indicated as primary therapy in stable disease with thymoma. - **Corticosteroids Alone**: May worsen symptoms initially (steroid-induced exacerbation) and are not definitive; used as adjunct after thymectomy or in seronegative MG without thymoma. - **Azathioprine Monotherapy**: A steroid-sparing immunosuppressant; used for long-term control but not as sole therapy in thymoma-associated MG. **Mnemonic: TIMELY** — **T**hymectomy for **I**mmunosuppression, **M**ediastinal mass, **E**arly intervention, **L**ong-term **Y** benefit.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.